Logo image of SYNX

SILYNXCOM LTD (SYNX) Stock Fundamental Analysis

NYSEARCA:SYNX - NYSE Arca - IL0011990749 - Common Stock - Currency: USD

1.71  -0.05 (-2.84%)

Fundamental Rating

3

SYNX gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 67 industry peers in the Aerospace & Defense industry. While SYNX seems to be doing ok healthwise, there are quite some concerns on its profitability. SYNX is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year SYNX has reported negative net income.
In the past year SYNX has reported a negative cash flow from operations.
SYNX Yearly Net Income VS EBIT VS OCF VS FCFSYNX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 0 1M -1M -2M

1.2 Ratios

SYNX has a Return On Assets of -39.38%. This is in the lower half of the industry: SYNX underperforms 79.10% of its industry peers.
Looking at the Return On Equity, with a value of -53.13%, SYNX is doing worse than 74.63% of the companies in the same industry.
Industry RankSector Rank
ROA -39.38%
ROE -53.13%
ROIC N/A
ROA(3y)-5.91%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
SYNX Yearly ROA, ROE, ROICSYNX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 0 100 -100 200

1.3 Margins

Looking at the Gross Margin, with a value of 44.80%, SYNX belongs to the top of the industry, outperforming 86.57% of the companies in the same industry.
SYNX does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 44.8%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
SYNX Yearly Profit, Operating, Gross MarginsSYNX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 0 20 -20 40

More info and screens

6

2. Health

2.1 Basic Checks

SYNX does not have a ROIC to compare to the WACC, probably because it is not profitable.
SYNX has about the same amout of shares outstanding than it did 1 year ago.
SYNX has a better debt/assets ratio than last year.
SYNX Yearly Shares OutstandingSYNX Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 1M 2M 3M 4M 5M
SYNX Yearly Total Debt VS Total AssetsSYNX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2M 4M 6M

2.2 Solvency

An Altman-Z score of 5.48 indicates that SYNX is not in any danger for bankruptcy at the moment.
SYNX's Altman-Z score of 5.48 is fine compared to the rest of the industry. SYNX outperforms 64.18% of its industry peers.
SYNX has a Debt/Equity ratio of 0.00. This is a healthy value indicating a solid balance between debt and equity.
SYNX has a Debt to Equity ratio of 0.00. This is amongst the best in the industry. SYNX outperforms 89.55% of its industry peers.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 5.48
ROIC/WACCN/A
WACC8.8%
SYNX Yearly LT Debt VS Equity VS FCFSYNX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 0 1M -1M 2M -2M

2.3 Liquidity

SYNX has a Current Ratio of 4.10. This indicates that SYNX is financially healthy and has no problem in meeting its short term obligations.
The Current ratio of SYNX (4.10) is better than 82.09% of its industry peers.
SYNX has a Quick Ratio of 2.88. This indicates that SYNX is financially healthy and has no problem in meeting its short term obligations.
With an excellent Quick ratio value of 2.88, SYNX belongs to the best of the industry, outperforming 83.58% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 4.1
Quick Ratio 2.88
SYNX Yearly Current Assets VS Current LiabilitesSYNX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 1M 2M 3M 4M 5M

More info and screens

4

3. Growth

3.1 Past

The earnings per share for SYNX have decreased strongly by -568.79% in the last year.
Looking at the last year, SYNX shows a very strong growth in Revenue. The Revenue has grown by 25.38%.
EPS 1Y (TTM)-568.79%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%69.35%
Revenue 1Y (TTM)25.38%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%73%

3.2 Future

SYNX is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 46.28% yearly.
Based on estimates for the next years, SYNX will show a very strong growth in Revenue. The Revenue will grow by 24.60% on average per year.
EPS Next Y106.45%
EPS Next 2Y46.28%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year50%
Revenue Next 2Y24.6%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

SYNX Yearly Revenue VS EstimatesSYNX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 2025 2M 4M 6M 8M 10M
SYNX Yearly EPS VS EstimatesSYNX Yearly EPS VS EstimatesYearly EPS VS Estimates 2023 2024 2025 0 -0.2 -0.4 -0.6 -0.8

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for SYNX. In the last year negative earnings were reported.
The Price/Forward Earnings ratio is 12.90, which indicates a correct valuation of SYNX.
98.51% of the companies in the same industry are more expensive than SYNX, based on the Price/Forward Earnings ratio.
SYNX is valuated cheaply when we compare the Price/Forward Earnings ratio to 34.09, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE N/A
Fwd PE 12.9
SYNX Price Earnings VS Forward Price EarningsSYNX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
SYNX Per share dataSYNX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5 1 1.5

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as SYNX's earnings are expected to grow with 46.28% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y46.28%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

SYNX does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

SILYNXCOM LTD

NYSEARCA:SYNX (8/11/2025, 3:38:17 PM)

1.71

-0.05 (-2.84%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryAerospace & Defense
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners17.85%
Inst Owner ChangeN/A
Ins Owners56.55%
Ins Owner ChangeN/A
Market Cap11.34M
AnalystsN/A
Price TargetN/A
Short Float %1.78%
Short Ratio0.41
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 12.9
P/S 0.87
P/FCF N/A
P/OCF N/A
P/B 1.71
P/tB 1.71
EV/EBITDA N/A
EPS(TTM)-0.67
EYN/A
EPS(NY)0.13
Fwd EY7.75%
FCF(TTM)-0.05
FCFYN/A
OCF(TTM)-0.05
OCFYN/A
SpS1.96
BVpS1
TBVpS1
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -39.38%
ROE -53.13%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 44.8%
FCFM N/A
ROA(3y)-5.91%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover1.46
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 34.45%
Cap/Sales 0.32%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 4.1
Quick Ratio 2.88
Altman-Z 5.48
F-Score4
WACC8.8%
ROIC/WACCN/A
Cap/Depr(3y)36.28%
Cap/Depr(5y)N/A
Cap/Sales(3y)0.45%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-568.79%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%69.35%
EPS Next Y106.45%
EPS Next 2Y46.28%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)25.38%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%73%
Revenue Next Year50%
Revenue Next 2Y24.6%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-36.04%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y141.61%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y141.98%
OCF growth 3YN/A
OCF growth 5YN/A